Correction to Furoxans (Oxadiazole-N-oxides) with Attenuated

Addition/Correction Cite This: J. Med. Chem. XXXX, XXX, XXX−XXX

pubs.acs.org/jmc

Correction to Furoxans (Oxadiazole‑N‑oxides) with Attenuated Reactivity Are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory Austin Horton, Kevin Nash, Ethel Tackie-Yarboi, Alexander Kostrevski, Adam Novak, Aparna Raghavan, Jatin Tulsulkar, Qasim Alhadidi, Nathan Wamer, Bryn Langenderfer, Kalee Royster, Maxwell Ducharme, Katelyn Hagood, Megan Post, Zahoor A. Shah, and Isaac T. Schiefer* Downloaded via 125.162.235.144 on June 22, 2018 at 07:26:58 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.

Journal of Medicinal Chemistry 2018, 61, 4593−4607. DOI: 10.1021/acs.jmedchem.8b00389 Page 4593. There is an error in the title, since furoxans are 1,2,5-oxadiazole-2N-oxides derivatives rather than 4N-oxides. The correct title should be “Furoxans (Oxadiazole-N-oxides) with Attenuated Reactivity Are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory”, as shown above. Note that the compounds are named correctly in the Experimental Section.

© XXXX American Chemical Society

A

DOI: 10.1021/acs.jmedchem.8b00891 J. Med. Chem. XXXX, XXX, XXX−XXX